KLRB1 and bladder transitional cell carcinoma: In 4 tumors, including ESCA, the expression of KLRB1 was positively correlated with drug sensitivity, while in 11 tumors, including BLCA, patients having low expression of KLRB1 would achieve a better response to chemotherapy.